SpliceBio

Biotechnology Research • Barcelona, Catalonia, Spain • 21-50 Employees

Company overview

Headquarters	Baldiri Reixac 10-12, Parc Cientific de Barcelona, Barcelona, Barcelona 08028, ES
Phone number	+34934020456
Websites	splice.bio proteodesign.es
Employees	21-50
Socials

Key Contacts at SpliceBio

Feride Sahin

Senior Director Clinical Development

Juan Pablo Labbrozzi

Senior Director - Cmc Development

Miquel Vila-Perello

Ceo

Marianna Di Scala

Head Of Translation & Director Of Non-Clinical Gene Therapy

Simon Eaglestone

Director Of Program Management

SpliceBio Email Formats

SpliceBio uses 4 email formats. The most common is {first name}.{last name} (e.g., john.doe@splice.bio), used 75.6% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@splice.bio	75.6%
{first initial}.{last name}	j.doe@splice.bio	20%
{first initial}.{second initial}	j.o@splice.bio	4.4%

About SpliceBio

SpliceBio is a biotechnology company exploiting Protein Splicing to develop the next generation of gene therapies. Our proprietary platform is based on technology developed in the Muir Lab at Princeton University after more than 20 years of pioneering intein and protein engineering research by our co-founders. The company is backed by UCB Ventures, Ysios Capital, NEA, Gilde Healthcare, Novartis Venture Fund and Asabys Partners.

SpliceBio revenue & valuation

Annual revenue	$66,500,000
Revenue per employee	$1,415,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$212,800,000
Total funding	$135,000,000